Compare BIO-TECHNE Corp (TECH) vs VNET Group Inc (VNET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs VNET Group Inc — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.36B), while VNET Group Inc trades at $5.53 (market cap $1.47B). The key difference: BIO-TECHNE Corp is far larger — about 7.7× VNET Group Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while VNET Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 64 Days and VNET Group Inc for 16 Days on average.
| TECH | VNET | |
|---|---|---|
Market Cap | $11.36B | $1.47B |
Volume | 5,390,331 | 4,955,295 |
Sector | Health | Technology |
52-Week High | $72.61 | $14.03 |
52-Week Low | $43.31 | $5.13 |
Typical Hold Time | 64 Days | 16 Days |
Enterprise Value | $11.39B | $5.04B |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.46, near its 52-week high of $72.70, with a slight daily decline of 0.1%. The stock shows a bullish technical signal from moving averages, while oscillators are neutral. Recent earnings have been mixed, with a Q2 2026 beat but a Q1 miss. The company maintains strong gross margins of 65.77%, though net income margin has compressed to 14.97% in 2025 from 24.6% in 2022. A significant development is the shareholder-approved acquisition by Merck KGaA at $73.00 per share, pending completion.
The pending acquisition at $73.00 offers a clear near-term upside of about 0.7% from the current price, limiting downside risk. However, execution risks remain until deal closure, and profitability pressures pose concerns for standalone operations. Analyst consensus is divided with 46% Buy and 54% Hold ratings, reflecting cautious optimism amid transition uncertainty.
VNET trades at $5.53, up 2.6% today but near 52-week lows. The technical picture is bearish with negative moving averages, while fundamentals show revenue growth to $9.95B in 2025 but persistent losses with a -22.18% net margin. Recent strategic investments and AI infrastructure partnerships provide growth catalysts, but balance sheet concerns and negative cash flow remain challenges.
Outlook remains cautious despite 62.5% analyst buy ratings. The stock offers speculative upside from AI data center demand and recent strategic investments, but risks include heavy debt load, negative profitability, and Chinese regulatory exposure. Investors should weigh growth potential against fundamental weaknesses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About VNET Group Inc
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →
